Predictive Oncology Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2013 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Predictive Oncology Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q1 2025.
  • Predictive Oncology Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2025 was $558.000, a 24% decline year-over-year.
  • Predictive Oncology Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2025 was $942.000.
  • Predictive Oncology Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1.12K, a 4.28% decline from 2023.
  • Predictive Oncology Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.17K, a 98.9% decline from 2022.
  • Predictive Oncology Inc. annual Share-based Payment Arrangement, Expense for 2022 was $109K, a 26% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.